Cedar Capital LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.7% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 2,353 shares of the healthcare conglomerate’s stock after selling 143 shares during the period. Cedar Capital LLC’s holdings in UnitedHealth Group were worth $386,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. B & T Capital Management DBA Alpha Capital Management boosted its position in UnitedHealth Group by 4.9% in the fourth quarter. B & T Capital Management DBA Alpha Capital Management now owns 1,606 shares of the healthcare conglomerate’s stock worth $257,000 after buying an additional 75 shares during the last quarter. Tyers Asset Management LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $7,186,000. Parallel Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $605,000. Cpcm LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $1,258,000. Finally, Flinton Capital Management LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $9,146,000. Institutional investors own 86.37% of the company’s stock.

Shares of UnitedHealth Group Incorporated (UNH) traded down 0.05% on Monday, reaching $194.78. 2,057,507 shares of the company’s stock traded hands. The firm’s 50 day moving average is $186.80 and its 200 day moving average is $173.05. The firm has a market capitalization of $191.86 billion, a P/E ratio of 23.40 and a beta of 0.64. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $195.41.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. UnitedHealth Group’s revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.96 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/07/cedar-capital-llc-has-386000-position-in-unitedhealth-group-incorporated-nyseunh-updated-updated-updated.html.

Several equities research analysts recently commented on the stock. UBS AG reissued a “buy” rating and set a $194.00 price objective (up previously from $193.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $205.00 target price (up from $200.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a report on Monday, July 10th. Credit Suisse Group reaffirmed an “outperform” rating and issued a $200.00 target price (up from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. Finally, Citigroup Inc. boosted their price objective on shares of UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. One equities research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $200.24.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total value of $913,200.00. Following the completion of the transaction, the director now owns 75,735 shares in the company, valued at $13,832,240.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of the stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the transaction, the director now owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. Insiders sold 15,540 shares of company stock valued at $2,873,320 in the last quarter. 0.89% of the stock is currently owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.